Capricor Therapeutics (NASDAQ:CAPR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.

Open	$14.62
Close	$14.53
Volume / Avg.	644.96K / 1.28M
Day Range	$14.21 - $14.86
52 Wk Range	3.52 - 23.40
Market Cap	$663.86M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	19.84%
Days to Cover	5.98

Recent News

America's Car-Mart Posts Upbeat Sales, Joins Methode Electronics, Verint Systems, Brown-Forman And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Capricor Therapeutics (CAPR) Shares Are Trading Lower

Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public offering of common stock.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.62
Close	$14.53
Volume / Avg.	644.96K / 1.28M
Day Range	$14.21 - $14.86
52 Wk Range	3.52 - 23.40
Market Cap	$663.86M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	19.84%
Days to Cover	5.98

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Capricor Therapeutics (CAPR) stock?

You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.

View our list of the best stock brokerages

Who are Capricor Therapeutics (CAPR) competitors?

Other companies in Capricor Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Cogent Biosciences (NASDAQ:COGT).

What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?

Capricor Therapeutics has a consensus price target of $39.29.

What is the current price for Capricor Therapeutics (CAPR)?

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $14.6 last updated January 23, 2025 at 6:53 PM EST.

Does Capricor Therapeutics (CAPR) pay a dividend?

There are no upcoming dividends for Capricor Therapeutics.

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

Capricor Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Capricor Therapeutics (CAPR) going to split?

There is no upcoming split for Capricor Therapeutics.

What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Capricor Therapeutics

Capricor Therapeutics (CAPR) Forecast